MedPath

PharmEvo Pvt Ltd.

PharmEvo Pvt Ltd. logo
🇵🇰Pakistan
Ownership
Private
Established
1999-01-01
Employees
1K
Market Cap
-
Website
http://www.pharmevo.biz

Clinical Trials

10

Active:0
Completed:6

Trial Phases

1 Phases

Phase 4:7

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (7 trials with phase data)• Click on a phase to view related trials

Phase 4
7 (100.0%)

Efficacy and Safety of Rivaroxiban Compare With Vitamin K Antagonist Warfarin

Phase 4
Withdrawn
Conditions
Mitral Valve Stenosis
Atrial Fibrillation
Interventions
First Posted Date
2018-09-17
Last Posted Date
2018-09-17
Lead Sponsor
PharmEvo Pvt Ltd
Registration Number
NCT03673605
Locations
🇵🇰

National Institute of Cardiovascular, Karachi, Sindh, Pakistan

Amlodipine VaLsartan Efficacy in Hypertensive Patients.A Real World Trial

Completed
Conditions
Essential Hypertension
Interventions
Drug: Valsartan, Amlodipine -
First Posted Date
2017-12-13
Last Posted Date
2018-11-08
Lead Sponsor
PharmEvo Pvt Ltd
Target Recruit Count
800
Registration Number
NCT03371797
Locations
🇵🇰

Medicell, Karachi, Sindh, Pakistan

FLIPS: Ferfer Liposomal Iron Performance Study

Phase 4
Completed
Conditions
Iron Deficiency Anemia
Interventions
First Posted Date
2017-04-13
Last Posted Date
2019-01-31
Lead Sponsor
PharmEvo Pvt Ltd
Target Recruit Count
400
Registration Number
NCT03112187
Locations
🇵🇰

Lubna Shahzad,Al-raheem surgical and Maternity Hospital, Daroghwala, Lahore, Sindh, Pakistan

Neotililty Trial: Effect of Coenzyme Q10 on Semen Parameters in Men With Idiopathic Infertility

Phase 4
Withdrawn
Conditions
Idiopathic Infertility
Interventions
First Posted Date
2017-04-07
Last Posted Date
2018-09-17
Lead Sponsor
PharmEvo Pvt Ltd
Registration Number
NCT03104998
Locations
🇵🇰

HillPark Hospital, Karachi, Pakistan

TEAM (Trial on Efficacy and Quality of Life Among Asthmatic Patient With Montelukast)

Phase 4
Completed
Conditions
Asthma
Interventions
Drug: Placebo
First Posted Date
2017-03-30
Last Posted Date
2018-07-09
Lead Sponsor
PharmEvo Pvt Ltd
Target Recruit Count
180
Registration Number
NCT03096327
Locations
🇵🇰

Dr. Nadeem Rizvi, Karachi, Sindh, Pakistan

  • Prev
  • 1
  • 2
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.